Continuously updated topic dossier

Gene therapy

Research involving gene-based interventions and ageing-related outcomes.

Checking source freshness…
Automated evidence frame

Can targeted genetic interventions alter age-related disease or function with durable, controllable safety?

How this is generated

Current evidence state

Approved therapies for specific conditions coexist with experimental ageing-related approaches; they are not interchangeable.

Known limits

Target choice, delivery, off-target effects, immune response, reversibility, durability, and long-term surveillance remain decisive.

Regulatory context

Authorization is product- and indication-specific; no category-wide longevity approval exists.

Building the latest evidence view…